nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—CYP1A1—Propofol—epilepsy syndrome	0.0569	0.511	CbGbCtD
Isoprenaline—CYP1A1—Phenobarbital—epilepsy syndrome	0.0544	0.489	CbGbCtD
Isoprenaline—PIK3R2—forebrain—epilepsy syndrome	0.00951	0.0714	CbGeAlD
Isoprenaline—MAPK1—hindbrain—epilepsy syndrome	0.0068	0.051	CbGeAlD
Isoprenaline—PIK3R3—telencephalon—epilepsy syndrome	0.00593	0.0445	CbGeAlD
Isoprenaline—PIK3R2—head—epilepsy syndrome	0.00545	0.0409	CbGeAlD
Isoprenaline—PIK3R2—nervous system—epilepsy syndrome	0.00516	0.0388	CbGeAlD
Isoprenaline—PIK3R1—telencephalon—epilepsy syndrome	0.00507	0.038	CbGeAlD
Isoprenaline—PIK3R2—central nervous system—epilepsy syndrome	0.00497	0.0373	CbGeAlD
Isoprenaline—PIK3R2—cerebellum—epilepsy syndrome	0.00486	0.0365	CbGeAlD
Isoprenaline—PIK3R1—medulla oblongata—epilepsy syndrome	0.00398	0.0299	CbGeAlD
Isoprenaline—PIK3R2—brain—epilepsy syndrome	0.00395	0.0296	CbGeAlD
Isoprenaline—MAPK1—brainstem—epilepsy syndrome	0.00389	0.0292	CbGeAlD
Isoprenaline—ADRBK1—forebrain—epilepsy syndrome	0.00381	0.0286	CbGeAlD
Isoprenaline—MAPK1—forebrain—epilepsy syndrome	0.00376	0.0282	CbGeAlD
Isoprenaline—PIK3R3—head—epilepsy syndrome	0.0037	0.0277	CbGeAlD
Isoprenaline—PIK3R1—midbrain—epilepsy syndrome	0.00364	0.0273	CbGeAlD
Isoprenaline—PIK3R1—spinal cord—epilepsy syndrome	0.00355	0.0267	CbGeAlD
Isoprenaline—ADRBK1—telencephalon—epilepsy syndrome	0.00351	0.0263	CbGeAlD
Isoprenaline—PIK3R3—nervous system—epilepsy syndrome	0.0035	0.0263	CbGeAlD
Isoprenaline—MAPK1—telencephalon—epilepsy syndrome	0.00346	0.0259	CbGeAlD
Isoprenaline—PIK3R3—central nervous system—epilepsy syndrome	0.00337	0.0253	CbGeAlD
Isoprenaline—PIK3R3—cerebellum—epilepsy syndrome	0.0033	0.0247	CbGeAlD
Isoprenaline—PIK3R1—cerebellum—epilepsy syndrome	0.00282	0.0211	CbGeAlD
Isoprenaline—PIK3R3—brain—epilepsy syndrome	0.00268	0.0201	CbGeAlD
Isoprenaline—MAPK1—spinal cord—epilepsy syndrome	0.00242	0.0182	CbGeAlD
Isoprenaline—PIK3R1—brain—epilepsy syndrome	0.00229	0.0172	CbGeAlD
Isoprenaline—ADRBK1—head—epilepsy syndrome	0.00218	0.0164	CbGeAlD
Isoprenaline—MAPK1—head—epilepsy syndrome	0.00215	0.0162	CbGeAlD
Isoprenaline—ADRBK1—nervous system—epilepsy syndrome	0.00207	0.0155	CbGeAlD
Isoprenaline—MAPK1—nervous system—epilepsy syndrome	0.00204	0.0153	CbGeAlD
Isoprenaline—ADRBK1—central nervous system—epilepsy syndrome	0.00199	0.015	CbGeAlD
Isoprenaline—MAPK1—central nervous system—epilepsy syndrome	0.00196	0.0147	CbGeAlD
Isoprenaline—ADRBK1—cerebellum—epilepsy syndrome	0.00195	0.0146	CbGeAlD
Isoprenaline—MAPK1—cerebellum—epilepsy syndrome	0.00192	0.0144	CbGeAlD
Isoprenaline—ADRB1—forebrain—epilepsy syndrome	0.0016	0.012	CbGeAlD
Isoprenaline—ADRBK1—brain—epilepsy syndrome	0.00158	0.0119	CbGeAlD
Isoprenaline—MAPK1—brain—epilepsy syndrome	0.00156	0.0117	CbGeAlD
Isoprenaline—ADRB1—telencephalon—epilepsy syndrome	0.00147	0.011	CbGeAlD
Isoprenaline—ADRB1—head—epilepsy syndrome	0.000914	0.00686	CbGeAlD
Isoprenaline—Terbutaline—BCHE—epilepsy syndrome	0.000886	0.13	CrCbGaD
Isoprenaline—ADRB1—nervous system—epilepsy syndrome	0.000866	0.0065	CbGeAlD
Isoprenaline—ADRB1—central nervous system—epilepsy syndrome	0.000834	0.00626	CbGeAlD
Isoprenaline—Tachycardia—Propofol—epilepsy syndrome	0.000779	0.00274	CcSEcCtD
Isoprenaline—Tension—Phenytoin—epilepsy syndrome	0.000779	0.00274	CcSEcCtD
Isoprenaline—Arrhythmia—Carbamazepine—epilepsy syndrome	0.000777	0.00274	CcSEcCtD
Isoprenaline—Tremor—Zonisamide—epilepsy syndrome	0.000777	0.00273	CcSEcCtD
Isoprenaline—Nervousness—Clonazepam—epilepsy syndrome	0.000776	0.00273	CcSEcCtD
Isoprenaline—Tension—Oxcarbazepine—epilepsy syndrome	0.000775	0.00273	CcSEcCtD
Isoprenaline—Palpitations—Diazepam—epilepsy syndrome	0.000773	0.00272	CcSEcCtD
Isoprenaline—Hyperhidrosis—Propofol—epilepsy syndrome	0.000771	0.00271	CcSEcCtD
Isoprenaline—Nervousness—Phenytoin—epilepsy syndrome	0.000771	0.00271	CcSEcCtD
Isoprenaline—Convulsion—Vigabatrin—epilepsy syndrome	0.00077	0.00271	CcSEcCtD
Isoprenaline—Nervousness—Oxcarbazepine—epilepsy syndrome	0.000767	0.0027	CcSEcCtD
Isoprenaline—Headache—Trimethadione—epilepsy syndrome	0.000762	0.00268	CcSEcCtD
Isoprenaline—Tachycardia—Midazolam—epilepsy syndrome	0.000762	0.00268	CcSEcCtD
Isoprenaline—Cardiac arrest—Gabapentin—epilepsy syndrome	0.000761	0.00268	CcSEcCtD
Isoprenaline—Asthenia—Rufinamide—epilepsy syndrome	0.000759	0.00267	CcSEcCtD
Isoprenaline—Vision blurred—Clonazepam—epilepsy syndrome	0.000753	0.00265	CcSEcCtD
Isoprenaline—Tremor—Clonazepam—epilepsy syndrome	0.000748	0.00263	CcSEcCtD
Isoprenaline—Palpitations—Felbamate—epilepsy syndrome	0.000748	0.00263	CcSEcCtD
Isoprenaline—Hypotension—Propofol—epilepsy syndrome	0.000746	0.00262	CcSEcCtD
Isoprenaline—Vertigo—Zonisamide—epilepsy syndrome	0.000745	0.00262	CcSEcCtD
Isoprenaline—Vision blurred—Oxcarbazepine—epilepsy syndrome	0.000744	0.00262	CcSEcCtD
Isoprenaline—Tremor—Phenytoin—epilepsy syndrome	0.000743	0.00262	CcSEcCtD
Isoprenaline—Tension—Carbamazepine—epilepsy syndrome	0.000743	0.00262	CcSEcCtD
Isoprenaline—Tremor—Oxcarbazepine—epilepsy syndrome	0.00074	0.0026	CcSEcCtD
Isoprenaline—Nervousness—Carbamazepine—epilepsy syndrome	0.000736	0.00259	CcSEcCtD
Isoprenaline—Angina pectoris—Pregabalin—epilepsy syndrome	0.000735	0.00259	CcSEcCtD
Isoprenaline—Palpitations—Zonisamide—epilepsy syndrome	0.000732	0.00258	CcSEcCtD
Isoprenaline—Hypertension—Felbamate—epilepsy syndrome	0.000731	0.00257	CcSEcCtD
Isoprenaline—Hypotension—Midazolam—epilepsy syndrome	0.00073	0.00257	CcSEcCtD
Isoprenaline—Tachycardia—Fosphenytoin—epilepsy syndrome	0.000726	0.00256	CcSEcCtD
Isoprenaline—Nausea—Trimethadione—epilepsy syndrome	0.000723	0.00254	CcSEcCtD
Isoprenaline—Insomnia—Propofol—epilepsy syndrome	0.000722	0.00254	CcSEcCtD
Isoprenaline—Hyperhidrosis—Fosphenytoin—epilepsy syndrome	0.000719	0.00253	CcSEcCtD
Isoprenaline—Tension—Lamotrigine—epilepsy syndrome	0.000718	0.00253	CcSEcCtD
Isoprenaline—Convulsion—Zonisamide—epilepsy syndrome	0.000718	0.00253	CcSEcCtD
Isoprenaline—Vertigo—Clonazepam—epilepsy syndrome	0.000718	0.00253	CcSEcCtD
Isoprenaline—Hypertension—Zonisamide—epilepsy syndrome	0.000716	0.00252	CcSEcCtD
Isoprenaline—Vision blurred—Carbamazepine—epilepsy syndrome	0.000714	0.00251	CcSEcCtD
Isoprenaline—Sweating—Valproic Acid—epilepsy syndrome	0.000714	0.00251	CcSEcCtD
Isoprenaline—Vertigo—Phenytoin—epilepsy syndrome	0.000713	0.00251	CcSEcCtD
Isoprenaline—Asthenia—Lacosamide—epilepsy syndrome	0.000713	0.00251	CcSEcCtD
Isoprenaline—Dizziness—Phenobarbital—epilepsy syndrome	0.000713	0.00251	CcSEcCtD
Isoprenaline—Dyspnoea—Propofol—epilepsy syndrome	0.000711	0.0025	CcSEcCtD
Isoprenaline—Nervousness—Lamotrigine—epilepsy syndrome	0.000711	0.0025	CcSEcCtD
Isoprenaline—Tremor—Carbamazepine—epilepsy syndrome	0.00071	0.0025	CcSEcCtD
Isoprenaline—Vertigo—Oxcarbazepine—epilepsy syndrome	0.000709	0.0025	CcSEcCtD
Isoprenaline—Palpitations—Clonazepam—epilepsy syndrome	0.000706	0.00248	CcSEcCtD
Isoprenaline—Palpitations—Phenytoin—epilepsy syndrome	0.000701	0.00247	CcSEcCtD
Isoprenaline—Dizziness—Rufinamide—epilepsy syndrome	0.000699	0.00246	CcSEcCtD
Isoprenaline—Palpitations—Oxcarbazepine—epilepsy syndrome	0.000698	0.00245	CcSEcCtD
Isoprenaline—Insomnia—Levetiracetam—epilepsy syndrome	0.000697	0.00245	CcSEcCtD
Isoprenaline—Tachycardia—Diazepam—epilepsy syndrome	0.000697	0.00245	CcSEcCtD
Isoprenaline—Dyspnoea—Midazolam—epilepsy syndrome	0.000696	0.00245	CcSEcCtD
Isoprenaline—Hypotension—Fosphenytoin—epilepsy syndrome	0.000695	0.00245	CcSEcCtD
Isoprenaline—Asthenia—Clobazam—epilepsy syndrome	0.000692	0.00243	CcSEcCtD
Isoprenaline—Hyperhidrosis—Diazepam—epilepsy syndrome	0.00069	0.00243	CcSEcCtD
Isoprenaline—Vision blurred—Lamotrigine—epilepsy syndrome	0.00069	0.00243	CcSEcCtD
Isoprenaline—Convulsion—Phenytoin—epilepsy syndrome	0.000688	0.00242	CcSEcCtD
Isoprenaline—Tremor—Lamotrigine—epilepsy syndrome	0.000686	0.00241	CcSEcCtD
Isoprenaline—Hypertension—Phenytoin—epilepsy syndrome	0.000685	0.00241	CcSEcCtD
Isoprenaline—Convulsion—Oxcarbazepine—epilepsy syndrome	0.000684	0.00241	CcSEcCtD
Isoprenaline—Hypertension—Oxcarbazepine—epilepsy syndrome	0.000681	0.0024	CcSEcCtD
Isoprenaline—Bronchospasm—Gabapentin—epilepsy syndrome	0.000681	0.0024	CcSEcCtD
Isoprenaline—Vertigo—Carbamazepine—epilepsy syndrome	0.000681	0.00239	CcSEcCtD
Isoprenaline—Headache—Phenobarbital—epilepsy syndrome	0.000675	0.00238	CcSEcCtD
Isoprenaline—Tachycardia—Felbamate—epilepsy syndrome	0.000675	0.00237	CcSEcCtD
Isoprenaline—Angina pectoris—Gabapentin—epilepsy syndrome	0.000674	0.00237	CcSEcCtD
Isoprenaline—Insomnia—Fosphenytoin—epilepsy syndrome	0.000673	0.00237	CcSEcCtD
Isoprenaline—Hyperhidrosis—Felbamate—epilepsy syndrome	0.000668	0.00235	CcSEcCtD
Isoprenaline—Hypotension—Diazepam—epilepsy syndrome	0.000667	0.00235	CcSEcCtD
Isoprenaline—Dyspnoea—Fosphenytoin—epilepsy syndrome	0.000663	0.00233	CcSEcCtD
Isoprenaline—Headache—Rufinamide—epilepsy syndrome	0.000663	0.00233	CcSEcCtD
Isoprenaline—ADRB1—brain—epilepsy syndrome	0.000662	0.00497	CbGeAlD
Isoprenaline—Tachycardia—Zonisamide—epilepsy syndrome	0.00066	0.00232	CcSEcCtD
Isoprenaline—Vertigo—Lamotrigine—epilepsy syndrome	0.000658	0.00231	CcSEcCtD
Isoprenaline—Dizziness—Lacosamide—epilepsy syndrome	0.000657	0.00231	CcSEcCtD
Isoprenaline—Convulsion—Carbamazepine—epilepsy syndrome	0.000656	0.00231	CcSEcCtD
Isoprenaline—Insomnia—Vigabatrin—epilepsy syndrome	0.000656	0.00231	CcSEcCtD
Isoprenaline—Hyperhidrosis—Zonisamide—epilepsy syndrome	0.000654	0.0023	CcSEcCtD
Isoprenaline—Hypertension—Carbamazepine—epilepsy syndrome	0.000654	0.0023	CcSEcCtD
Isoprenaline—Palpitations—Lamotrigine—epilepsy syndrome	0.000647	0.00228	CcSEcCtD
Isoprenaline—Insomnia—Diazepam—epilepsy syndrome	0.000646	0.00227	CcSEcCtD
Isoprenaline—Hypotension—Felbamate—epilepsy syndrome	0.000646	0.00227	CcSEcCtD
Isoprenaline—Sweating—Pregabalin—epilepsy syndrome	0.000645	0.00227	CcSEcCtD
Isoprenaline—Nausea—Phenobarbital—epilepsy syndrome	0.00064	0.00225	CcSEcCtD
Isoprenaline—Methyldopa—ADRA2A—epilepsy syndrome	0.000639	0.0938	CrCbGaD
Isoprenaline—Dizziness—Clobazam—epilepsy syndrome	0.000637	0.00224	CcSEcCtD
Isoprenaline—Dyspnoea—Diazepam—epilepsy syndrome	0.000637	0.00224	CcSEcCtD
Isoprenaline—Tachycardia—Clonazepam—epilepsy syndrome	0.000636	0.00224	CcSEcCtD
Isoprenaline—Convulsion—Lamotrigine—epilepsy syndrome	0.000634	0.00223	CcSEcCtD
Isoprenaline—Hypotension—Zonisamide—epilepsy syndrome	0.000632	0.00222	CcSEcCtD
Isoprenaline—Tachycardia—Phenytoin—epilepsy syndrome	0.000632	0.00222	CcSEcCtD
Isoprenaline—Hypertension—Lamotrigine—epilepsy syndrome	0.000632	0.00222	CcSEcCtD
Isoprenaline—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000629	0.00221	CcSEcCtD
Isoprenaline—Nausea—Rufinamide—epilepsy syndrome	0.000628	0.00221	CcSEcCtD
Isoprenaline—Hyperhidrosis—Phenytoin—epilepsy syndrome	0.000626	0.0022	CcSEcCtD
Isoprenaline—Insomnia—Felbamate—epilepsy syndrome	0.000625	0.0022	CcSEcCtD
Isoprenaline—Hyperhidrosis—Oxcarbazepine—epilepsy syndrome	0.000623	0.00219	CcSEcCtD
Isoprenaline—Headache—Lacosamide—epilepsy syndrome	0.000622	0.00219	CcSEcCtD
Isoprenaline—Asthenia—Acetazolamide—epilepsy syndrome	0.000616	0.00217	CcSEcCtD
Isoprenaline—Dyspnoea—Felbamate—epilepsy syndrome	0.000616	0.00217	CcSEcCtD
Isoprenaline—Insomnia—Zonisamide—epilepsy syndrome	0.000612	0.00215	CcSEcCtD
Isoprenaline—Hypotension—Clonazepam—epilepsy syndrome	0.000609	0.00214	CcSEcCtD
Isoprenaline—Hypotension—Phenytoin—epilepsy syndrome	0.000605	0.00213	CcSEcCtD
Isoprenaline—Headache—Clobazam—epilepsy syndrome	0.000604	0.00213	CcSEcCtD
Isoprenaline—Tachycardia—Carbamazepine—epilepsy syndrome	0.000603	0.00212	CcSEcCtD
Isoprenaline—Dyspnoea—Zonisamide—epilepsy syndrome	0.000603	0.00212	CcSEcCtD
Isoprenaline—Hypotension—Oxcarbazepine—epilepsy syndrome	0.000602	0.00212	CcSEcCtD
Isoprenaline—Hyperhidrosis—Carbamazepine—epilepsy syndrome	0.000598	0.0021	CcSEcCtD
Isoprenaline—Arrhythmia—Valproic Acid—epilepsy syndrome	0.000597	0.0021	CcSEcCtD
Isoprenaline—Sweating—Gabapentin—epilepsy syndrome	0.000592	0.00208	CcSEcCtD
Isoprenaline—Nausea—Lacosamide—epilepsy syndrome	0.00059	0.00208	CcSEcCtD
Isoprenaline—Insomnia—Clonazepam—epilepsy syndrome	0.00059	0.00208	CcSEcCtD
Isoprenaline—CYP1A1—head—epilepsy syndrome	0.000589	0.00442	CbGeAlD
Isoprenaline—Insomnia—Phenytoin—epilepsy syndrome	0.000586	0.00206	CcSEcCtD
Isoprenaline—Tachycardia—Lamotrigine—epilepsy syndrome	0.000583	0.00205	CcSEcCtD
Isoprenaline—Insomnia—Oxcarbazepine—epilepsy syndrome	0.000583	0.00205	CcSEcCtD
Isoprenaline—Dyspnoea—Clonazepam—epilepsy syndrome	0.000581	0.00205	CcSEcCtD
Isoprenaline—Hypotension—Carbamazepine—epilepsy syndrome	0.000578	0.00203	CcSEcCtD
Isoprenaline—Hyperhidrosis—Lamotrigine—epilepsy syndrome	0.000578	0.00203	CcSEcCtD
Isoprenaline—Dyspnoea—Phenytoin—epilepsy syndrome	0.000577	0.00203	CcSEcCtD
Isoprenaline—Dyspnoea—Oxcarbazepine—epilepsy syndrome	0.000574	0.00202	CcSEcCtD
Isoprenaline—Nausea—Clobazam—epilepsy syndrome	0.000573	0.00201	CcSEcCtD
Isoprenaline—Asthenia—Propofol—epilepsy syndrome	0.000573	0.00201	CcSEcCtD
Isoprenaline—Tension—Valproic Acid—epilepsy syndrome	0.000571	0.00201	CcSEcCtD
Isoprenaline—Dizziness—Acetazolamide—epilepsy syndrome	0.000568	0.002	CcSEcCtD
Isoprenaline—Angina pectoris—Topiramate—epilepsy syndrome	0.000567	0.002	CcSEcCtD
Isoprenaline—Levonordefrin—ADRA2A—epilepsy syndrome	0.000566	0.0831	CrCbGaD
Isoprenaline—Nervousness—Valproic Acid—epilepsy syndrome	0.000565	0.00199	CcSEcCtD
Isoprenaline—Flushing—Pregabalin—epilepsy syndrome	0.000561	0.00197	CcSEcCtD
Isoprenaline—Asthenia—Midazolam—epilepsy syndrome	0.00056	0.00197	CcSEcCtD
Isoprenaline—Insomnia—Carbamazepine—epilepsy syndrome	0.000559	0.00197	CcSEcCtD
Isoprenaline—CYP1A1—nervous system—epilepsy syndrome	0.000559	0.00419	CbGeAlD
Isoprenaline—Asthenia—Levetiracetam—epilepsy syndrome	0.000553	0.00195	CcSEcCtD
Isoprenaline—Dyspnoea—Carbamazepine—epilepsy syndrome	0.000551	0.00194	CcSEcCtD
Isoprenaline—Vision blurred—Valproic Acid—epilepsy syndrome	0.000548	0.00193	CcSEcCtD
Isoprenaline—Tremor—Valproic Acid—epilepsy syndrome	0.000545	0.00192	CcSEcCtD
Isoprenaline—Insomnia—Lamotrigine—epilepsy syndrome	0.00054	0.0019	CcSEcCtD
Isoprenaline—Arrhythmia—Pregabalin—epilepsy syndrome	0.00054	0.0019	CcSEcCtD
Isoprenaline—Headache—Acetazolamide—epilepsy syndrome	0.000538	0.00189	CcSEcCtD
Isoprenaline—CYP1A1—central nervous system—epilepsy syndrome	0.000538	0.00404	CbGeAlD
Isoprenaline—Asthenia—Fosphenytoin—epilepsy syndrome	0.000534	0.00188	CcSEcCtD
Isoprenaline—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000533	0.00187	CcSEcCtD
Isoprenaline—Dizziness—Propofol—epilepsy syndrome	0.000528	0.00186	CcSEcCtD
Isoprenaline—Vertigo—Valproic Acid—epilepsy syndrome	0.000523	0.00184	CcSEcCtD
Isoprenaline—Asthenia—Vigabatrin—epilepsy syndrome	0.00052	0.00183	CcSEcCtD
Isoprenaline—Dizziness—Midazolam—epilepsy syndrome	0.000516	0.00182	CcSEcCtD
Isoprenaline—Tension—Pregabalin—epilepsy syndrome	0.000516	0.00182	CcSEcCtD
Isoprenaline—Palpitations—Valproic Acid—epilepsy syndrome	0.000514	0.00181	CcSEcCtD
Isoprenaline—Asthenia—Diazepam—epilepsy syndrome	0.000512	0.0018	CcSEcCtD
Isoprenaline—Nervousness—Pregabalin—epilepsy syndrome	0.000511	0.0018	CcSEcCtD
Isoprenaline—Nausea—Acetazolamide—epilepsy syndrome	0.00051	0.0018	CcSEcCtD
Isoprenaline—Dizziness—Levetiracetam—epilepsy syndrome	0.00051	0.00179	CcSEcCtD
Isoprenaline—Hypertension—Valproic Acid—epilepsy syndrome	0.000502	0.00177	CcSEcCtD
Isoprenaline—Headache—Propofol—epilepsy syndrome	0.0005	0.00176	CcSEcCtD
Isoprenaline—Asthenia—Felbamate—epilepsy syndrome	0.000496	0.00175	CcSEcCtD
Isoprenaline—Vision blurred—Pregabalin—epilepsy syndrome	0.000496	0.00174	CcSEcCtD
Isoprenaline—Tremor—Pregabalin—epilepsy syndrome	0.000493	0.00173	CcSEcCtD
Isoprenaline—Dizziness—Fosphenytoin—epilepsy syndrome	0.000492	0.00173	CcSEcCtD
Isoprenaline—Headache—Midazolam—epilepsy syndrome	0.000489	0.00172	CcSEcCtD
Isoprenaline—Arformoterol—CYP2C19—epilepsy syndrome	0.000487	0.0716	CrCbGaD
Isoprenaline—Formoterol—CYP2C19—epilepsy syndrome	0.000487	0.0716	CrCbGaD
Isoprenaline—Asthenia—Zonisamide—epilepsy syndrome	0.000485	0.00171	CcSEcCtD
Isoprenaline—Headache—Levetiracetam—epilepsy syndrome	0.000483	0.0017	CcSEcCtD
Isoprenaline—Dizziness—Vigabatrin—epilepsy syndrome	0.00048	0.00169	CcSEcCtD
Isoprenaline—Nausea—Propofol—epilepsy syndrome	0.000474	0.00167	CcSEcCtD
Isoprenaline—Tension—Gabapentin—epilepsy syndrome	0.000473	0.00167	CcSEcCtD
Isoprenaline—Vertigo—Pregabalin—epilepsy syndrome	0.000472	0.00166	CcSEcCtD
Isoprenaline—Dizziness—Diazepam—epilepsy syndrome	0.000472	0.00166	CcSEcCtD
Isoprenaline—Nervousness—Gabapentin—epilepsy syndrome	0.000468	0.00165	CcSEcCtD
Isoprenaline—Asthenia—Clonazepam—epilepsy syndrome	0.000468	0.00165	CcSEcCtD
Isoprenaline—Headache—Fosphenytoin—epilepsy syndrome	0.000466	0.00164	CcSEcCtD
Isoprenaline—Palpitations—Pregabalin—epilepsy syndrome	0.000465	0.00164	CcSEcCtD
Isoprenaline—Asthenia—Phenytoin—epilepsy syndrome	0.000465	0.00164	CcSEcCtD
Isoprenaline—Nausea—Midazolam—epilepsy syndrome	0.000464	0.00163	CcSEcCtD
Isoprenaline—Tachycardia—Valproic Acid—epilepsy syndrome	0.000463	0.00163	CcSEcCtD
Isoprenaline—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000462	0.00163	CcSEcCtD
Isoprenaline—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000459	0.00162	CcSEcCtD
Isoprenaline—Nausea—Levetiracetam—epilepsy syndrome	0.000458	0.00161	CcSEcCtD
Isoprenaline—Dizziness—Felbamate—epilepsy syndrome	0.000457	0.00161	CcSEcCtD
Isoprenaline—Convulsion—Pregabalin—epilepsy syndrome	0.000456	0.0016	CcSEcCtD
Isoprenaline—Vision blurred—Gabapentin—epilepsy syndrome	0.000454	0.0016	CcSEcCtD
Isoprenaline—Headache—Vigabatrin—epilepsy syndrome	0.000454	0.0016	CcSEcCtD
Isoprenaline—Hypertension—Pregabalin—epilepsy syndrome	0.000454	0.0016	CcSEcCtD
Isoprenaline—Tremor—Gabapentin—epilepsy syndrome	0.000452	0.00159	CcSEcCtD
Isoprenaline—Dizziness—Zonisamide—epilepsy syndrome	0.000447	0.00157	CcSEcCtD
Isoprenaline—Headache—Diazepam—epilepsy syndrome	0.000447	0.00157	CcSEcCtD
Isoprenaline—Hypotension—Valproic Acid—epilepsy syndrome	0.000444	0.00156	CcSEcCtD
Isoprenaline—Asthenia—Carbamazepine—epilepsy syndrome	0.000444	0.00156	CcSEcCtD
Isoprenaline—Nausea—Fosphenytoin—epilepsy syndrome	0.000442	0.00156	CcSEcCtD
Isoprenaline—Vertigo—Gabapentin—epilepsy syndrome	0.000433	0.00152	CcSEcCtD
Isoprenaline—Headache—Felbamate—epilepsy syndrome	0.000433	0.00152	CcSEcCtD
Isoprenaline—Flushing—Topiramate—epilepsy syndrome	0.000433	0.00152	CcSEcCtD
Isoprenaline—Dizziness—Clonazepam—epilepsy syndrome	0.000431	0.00152	CcSEcCtD
Isoprenaline—Nausea—Vigabatrin—epilepsy syndrome	0.000431	0.00152	CcSEcCtD
Isoprenaline—Insomnia—Valproic Acid—epilepsy syndrome	0.000429	0.00151	CcSEcCtD
Isoprenaline—Asthenia—Lamotrigine—epilepsy syndrome	0.000429	0.00151	CcSEcCtD
Isoprenaline—Dizziness—Phenytoin—epilepsy syndrome	0.000428	0.00151	CcSEcCtD
Isoprenaline—CYP1A1—brain—epilepsy syndrome	0.000427	0.0032	CbGeAlD
Isoprenaline—Palpitations—Gabapentin—epilepsy syndrome	0.000426	0.0015	CcSEcCtD
Isoprenaline—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000426	0.0015	CcSEcCtD
Isoprenaline—Nausea—Diazepam—epilepsy syndrome	0.000424	0.00149	CcSEcCtD
Isoprenaline—Headache—Zonisamide—epilepsy syndrome	0.000424	0.00149	CcSEcCtD
Isoprenaline—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000423	0.00149	CcSEcCtD
Isoprenaline—Tachycardia—Pregabalin—epilepsy syndrome	0.000419	0.00147	CcSEcCtD
Isoprenaline—Convulsion—Gabapentin—epilepsy syndrome	0.000418	0.00147	CcSEcCtD
Isoprenaline—Hypertension—Gabapentin—epilepsy syndrome	0.000416	0.00147	CcSEcCtD
Isoprenaline—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000415	0.00146	CcSEcCtD
Isoprenaline—Nausea—Felbamate—epilepsy syndrome	0.000411	0.00144	CcSEcCtD
Isoprenaline—Dizziness—Carbamazepine—epilepsy syndrome	0.000409	0.00144	CcSEcCtD
Isoprenaline—Headache—Clonazepam—epilepsy syndrome	0.000408	0.00144	CcSEcCtD
Isoprenaline—Headache—Phenytoin—epilepsy syndrome	0.000406	0.00143	CcSEcCtD
Isoprenaline—Headache—Oxcarbazepine—epilepsy syndrome	0.000404	0.00142	CcSEcCtD
Isoprenaline—Nausea—Zonisamide—epilepsy syndrome	0.000402	0.00141	CcSEcCtD
Isoprenaline—Hypotension—Pregabalin—epilepsy syndrome	0.000401	0.00141	CcSEcCtD
Isoprenaline—Droxidopa—ADRA2A—epilepsy syndrome	0.000399	0.0586	CrCbGaD
Isoprenaline—Tension—Topiramate—epilepsy syndrome	0.000398	0.0014	CcSEcCtD
Isoprenaline—Dizziness—Lamotrigine—epilepsy syndrome	0.000395	0.00139	CcSEcCtD
Isoprenaline—Nervousness—Topiramate—epilepsy syndrome	0.000394	0.00139	CcSEcCtD
Isoprenaline—Insomnia—Pregabalin—epilepsy syndrome	0.000388	0.00137	CcSEcCtD
Isoprenaline—Nausea—Clonazepam—epilepsy syndrome	0.000387	0.00136	CcSEcCtD
Isoprenaline—Headache—Carbamazepine—epilepsy syndrome	0.000387	0.00136	CcSEcCtD
Isoprenaline—Nausea—Phenytoin—epilepsy syndrome	0.000385	0.00135	CcSEcCtD
Isoprenaline—Tachycardia—Gabapentin—epilepsy syndrome	0.000384	0.00135	CcSEcCtD
Isoprenaline—Dyspnoea—Pregabalin—epilepsy syndrome	0.000383	0.00135	CcSEcCtD
Isoprenaline—Nausea—Oxcarbazepine—epilepsy syndrome	0.000383	0.00135	CcSEcCtD
Isoprenaline—Vision blurred—Topiramate—epilepsy syndrome	0.000382	0.00135	CcSEcCtD
Isoprenaline—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.00038	0.00134	CcSEcCtD
Isoprenaline—Tremor—Topiramate—epilepsy syndrome	0.00038	0.00134	CcSEcCtD
Isoprenaline—Headache—Lamotrigine—epilepsy syndrome	0.000374	0.00132	CcSEcCtD
Isoprenaline—Hypotension—Gabapentin—epilepsy syndrome	0.000368	0.00129	CcSEcCtD
Isoprenaline—Nausea—Carbamazepine—epilepsy syndrome	0.000367	0.00129	CcSEcCtD
Isoprenaline—Vertigo—Topiramate—epilepsy syndrome	0.000364	0.00128	CcSEcCtD
Isoprenaline—Dopamine—HTR7—epilepsy syndrome	0.000364	0.0534	CrCbGaD
Isoprenaline—Formoterol—CYP2D6—epilepsy syndrome	0.000361	0.0531	CrCbGaD
Isoprenaline—Arformoterol—CYP2D6—epilepsy syndrome	0.000361	0.0531	CrCbGaD
Isoprenaline—Palpitations—Topiramate—epilepsy syndrome	0.000359	0.00126	CcSEcCtD
Isoprenaline—Insomnia—Gabapentin—epilepsy syndrome	0.000356	0.00125	CcSEcCtD
Isoprenaline—Nausea—Lamotrigine—epilepsy syndrome	0.000355	0.00125	CcSEcCtD
Isoprenaline—Convulsion—Topiramate—epilepsy syndrome	0.000352	0.00124	CcSEcCtD
Isoprenaline—Dyspnoea—Gabapentin—epilepsy syndrome	0.000351	0.00123	CcSEcCtD
Isoprenaline—Hypertension—Topiramate—epilepsy syndrome	0.00035	0.00123	CcSEcCtD
Isoprenaline—Asthenia—Valproic Acid—epilepsy syndrome	0.000341	0.0012	CcSEcCtD
Isoprenaline—Norepinephrine—ADRA2A—epilepsy syndrome	0.000336	0.0493	CrCbGaD
Isoprenaline—Tachycardia—Topiramate—epilepsy syndrome	0.000323	0.00114	CcSEcCtD
Isoprenaline—Hyperhidrosis—Topiramate—epilepsy syndrome	0.00032	0.00113	CcSEcCtD
Isoprenaline—Dizziness—Valproic Acid—epilepsy syndrome	0.000314	0.0011	CcSEcCtD
Isoprenaline—Hypotension—Topiramate—epilepsy syndrome	0.000309	0.00109	CcSEcCtD
Isoprenaline—Asthenia—Pregabalin—epilepsy syndrome	0.000308	0.00108	CcSEcCtD
Isoprenaline—Epinephrine—ADRA2A—epilepsy syndrome	0.000304	0.0447	CrCbGaD
Isoprenaline—Insomnia—Topiramate—epilepsy syndrome	0.000299	0.00105	CcSEcCtD
Isoprenaline—Headache—Valproic Acid—epilepsy syndrome	0.000297	0.00105	CcSEcCtD
Isoprenaline—Dyspnoea—Topiramate—epilepsy syndrome	0.000295	0.00104	CcSEcCtD
Isoprenaline—Epinephrine—TNF—epilepsy syndrome	0.000289	0.0424	CrCbGaD
Isoprenaline—Dizziness—Pregabalin—epilepsy syndrome	0.000284	0.000999	CcSEcCtD
Isoprenaline—Asthenia—Gabapentin—epilepsy syndrome	0.000282	0.000994	CcSEcCtD
Isoprenaline—Nausea—Valproic Acid—epilepsy syndrome	0.000282	0.000992	CcSEcCtD
Isoprenaline—Headache—Pregabalin—epilepsy syndrome	0.000269	0.000946	CcSEcCtD
Isoprenaline—Labetalol—CYP2D6—epilepsy syndrome	0.000264	0.0388	CrCbGaD
Isoprenaline—Dizziness—Gabapentin—epilepsy syndrome	0.00026	0.000916	CcSEcCtD
Isoprenaline—Nausea—Pregabalin—epilepsy syndrome	0.000255	0.000897	CcSEcCtD
Isoprenaline—Pindolol—CYP2D6—epilepsy syndrome	0.000253	0.0372	CrCbGaD
Isoprenaline—Headache—Gabapentin—epilepsy syndrome	0.000247	0.000868	CcSEcCtD
Isoprenaline—Dopamine—SLC6A4—epilepsy syndrome	0.000238	0.035	CrCbGaD
Isoprenaline—Asthenia—Topiramate—epilepsy syndrome	0.000238	0.000836	CcSEcCtD
Isoprenaline—Nausea—Gabapentin—epilepsy syndrome	0.000234	0.000823	CcSEcCtD
Isoprenaline—Dopamine—CYP2C19—epilepsy syndrome	0.000226	0.0331	CrCbGaD
Isoprenaline—Dizziness—Topiramate—epilepsy syndrome	0.000219	0.000771	CcSEcCtD
Isoprenaline—Headache—Topiramate—epilepsy syndrome	0.000207	0.00073	CcSEcCtD
Isoprenaline—Nausea—Topiramate—epilepsy syndrome	0.000197	0.000692	CcSEcCtD
Isoprenaline—L-DOPA—CYP2D6—epilepsy syndrome	0.00018	0.0264	CrCbGaD
Isoprenaline—Dopamine—CYP2D6—epilepsy syndrome	0.000167	0.0246	CrCbGaD
Isoprenaline—MAPK1—Signaling by GPCR—CCL2—epilepsy syndrome	6.52e-06	1.4e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ADRA2A—epilepsy syndrome	6.52e-06	1.4e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NTRK2—epilepsy syndrome	6.52e-06	1.4e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCR2—epilepsy syndrome	6.52e-06	1.4e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—SST—epilepsy syndrome	6.52e-06	1.4e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PLAT—epilepsy syndrome	6.49e-06	1.4e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—SRC—epilepsy syndrome	6.49e-06	1.4e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—DUSP6—epilepsy syndrome	6.46e-06	1.39e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—JUN—epilepsy syndrome	6.45e-06	1.39e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—KDR—epilepsy syndrome	6.45e-06	1.39e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—JUN—epilepsy syndrome	6.44e-06	1.39e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ADRA2A—epilepsy syndrome	6.38e-06	1.37e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—TNF—epilepsy syndrome	6.38e-06	1.37e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—PRKCB—epilepsy syndrome	6.36e-06	1.37e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PLAT—epilepsy syndrome	6.35e-06	1.37e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL6ST—epilepsy syndrome	6.33e-06	1.36e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—FGF2—epilepsy syndrome	6.32e-06	1.36e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—ALB—epilepsy syndrome	6.32e-06	1.36e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—MMP9—epilepsy syndrome	6.28e-06	1.35e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—BDKRB2—epilepsy syndrome	6.27e-06	1.35e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CXCL12—epilepsy syndrome	6.27e-06	1.35e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—POMC—epilepsy syndrome	6.26e-06	1.35e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—PRKCB—epilepsy syndrome	6.24e-06	1.34e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—FGF2—epilepsy syndrome	6.23e-06	1.34e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL6ST—epilepsy syndrome	6.21e-06	1.34e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—PRKCB—epilepsy syndrome	6.21e-06	1.34e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—S100B—epilepsy syndrome	6.2e-06	1.33e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL6ST—epilepsy syndrome	6.18e-06	1.33e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—AKT1—epilepsy syndrome	6.17e-06	1.33e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—JUNB—epilepsy syndrome	6.15e-06	1.32e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CNR1—epilepsy syndrome	6.15e-06	1.32e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—IL6ST—epilepsy syndrome	6.15e-06	1.32e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—SOCS3—epilepsy syndrome	6.14e-06	1.32e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CXCL12—epilepsy syndrome	6.13e-06	1.32e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—BDKRB2—epilepsy syndrome	6.13e-06	1.32e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PLCB1—epilepsy syndrome	6.13e-06	1.32e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CDC42—epilepsy syndrome	6.12e-06	1.32e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—POMC—epilepsy syndrome	6.12e-06	1.32e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—PRKCB—epilepsy syndrome	6.1e-06	1.31e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—FOS—epilepsy syndrome	6.1e-06	1.31e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ABCG2—epilepsy syndrome	6.1e-06	1.31e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—NOS2—epilepsy syndrome	6.1e-06	1.31e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—AKT1—epilepsy syndrome	6.09e-06	1.31e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL6ST—epilepsy syndrome	6.08e-06	1.31e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CNR1—epilepsy syndrome	6.02e-06	1.3e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—JUNB—epilepsy syndrome	6.02e-06	1.3e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HTR7—epilepsy syndrome	6e-06	1.29e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PLCB1—epilepsy syndrome	5.99e-06	1.29e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CASP8—epilepsy syndrome	5.96e-06	1.28e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CYP2C19—epilepsy syndrome	5.95e-06	1.28e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—AVP—epilepsy syndrome	5.93e-06	1.28e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—AKT1—epilepsy syndrome	5.92e-06	1.28e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CYP11A1—epilepsy syndrome	5.91e-06	1.27e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HTR7—epilepsy syndrome	5.87e-06	1.26e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—RELA—epilepsy syndrome	5.87e-06	1.26e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.87e-06	1.26e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HBEGF—epilepsy syndrome	5.82e-06	1.25e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—POMC—epilepsy syndrome	5.79e-06	1.25e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—SRC—epilepsy syndrome	5.79e-06	1.25e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—RELA—epilepsy syndrome	5.78e-06	1.24e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—SRC—epilepsy syndrome	5.78e-06	1.24e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MTOR—epilepsy syndrome	5.76e-06	1.24e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—AKT3—epilepsy syndrome	5.72e-06	1.23e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HBEGF—epilepsy syndrome	5.7e-06	1.23e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—POMC—epilepsy syndrome	5.68e-06	1.22e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MTOR—epilepsy syndrome	5.67e-06	1.22e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CCL2—epilepsy syndrome	5.67e-06	1.22e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—POMC—epilepsy syndrome	5.65e-06	1.22e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—VEGFA—epilepsy syndrome	5.64e-06	1.21e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HES1—epilepsy syndrome	5.6e-06	1.21e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—AKT3—epilepsy syndrome	5.59e-06	1.2e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ADAM10—epilepsy syndrome	5.58e-06	1.2e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—AKT1—epilepsy syndrome	5.56e-06	1.2e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CCL2—epilepsy syndrome	5.56e-06	1.2e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—POMC—epilepsy syndrome	5.56e-06	1.2e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CCL2—epilepsy syndrome	5.53e-06	1.19e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—PTGS2—epilepsy syndrome	5.53e-06	1.19e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ADAM10—epilepsy syndrome	5.46e-06	1.18e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—FYN—epilepsy syndrome	5.45e-06	1.17e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CCL2—epilepsy syndrome	5.44e-06	1.17e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—H2AFX—epilepsy syndrome	5.43e-06	1.17e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MEF2C—epilepsy syndrome	5.42e-06	1.17e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—FGF2—epilepsy syndrome	5.39e-06	1.16e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.35e-06	1.15e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—GPCR downstream signaling—AKT1—epilepsy syndrome	5.34e-06	1.15e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—SRC—epilepsy syndrome	5.34e-06	1.15e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CYP2D6—epilepsy syndrome	5.33e-06	1.15e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CASP3—epilepsy syndrome	5.29e-06	1.14e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—S100B—epilepsy syndrome	5.28e-06	1.14e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—GPCR downstream signaling—AKT1—epilepsy syndrome	5.26e-06	1.13e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—YWHAZ—epilepsy syndrome	5.24e-06	1.13e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—SOCS3—epilepsy syndrome	5.23e-06	1.13e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CDC42—epilepsy syndrome	5.22e-06	1.12e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CASP3—epilepsy syndrome	5.21e-06	1.12e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NGF—epilepsy syndrome	5.18e-06	1.12e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—S100B—epilepsy syndrome	5.17e-06	1.11e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—JUN—epilepsy syndrome	5.14e-06	1.11e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—AKT1—epilepsy syndrome	5.14e-06	1.11e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—FGF2—epilepsy syndrome	5.12e-06	1.1e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—SOCS3—epilepsy syndrome	5.12e-06	1.1e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—BCL2—epilepsy syndrome	5.11e-06	1.1e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CDC42—epilepsy syndrome	5.1e-06	1.1e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ADRA2A—epilepsy syndrome	5.08e-06	1.09e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—JUN—epilepsy syndrome	5.07e-06	1.09e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—BCHE—epilepsy syndrome	5.06e-06	1.09e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—AVP—epilepsy syndrome	5.05e-06	1.09e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCR5—epilepsy syndrome	5.04e-06	1.08e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MMP9—epilepsy syndrome	5e-06	1.08e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—FGF2—epilepsy syndrome	5e-06	1.08e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—RELA—epilepsy syndrome	5e-06	1.08e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—FGF2—epilepsy syndrome	4.97e-06	1.07e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—AVP—epilepsy syndrome	4.94e-06	1.06e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HTR2A—epilepsy syndrome	4.93e-06	1.06e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MMP9—epilepsy syndrome	4.93e-06	1.06e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—MTOR—epilepsy syndrome	4.9e-06	1.06e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—AKT1—epilepsy syndrome	4.85e-06	1.04e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—SLC2A1—epilepsy syndrome	4.82e-06	1.04e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—AKT1—epilepsy syndrome	4.78e-06	1.03e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HES1—epilepsy syndrome	4.78e-06	1.03e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PLCB1—epilepsy syndrome	4.77e-06	1.03e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—RELA—epilepsy syndrome	4.76e-06	1.02e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—TH—epilepsy syndrome	4.75e-06	1.02e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—AKT1—epilepsy syndrome	4.75e-06	1.02e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TSC2—epilepsy syndrome	4.68e-06	1.01e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.68e-06	1.01e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—AGT—epilepsy syndrome	4.68e-06	1.01e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HES1—epilepsy syndrome	4.67e-06	1.01e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MTOR—epilepsy syndrome	4.66e-06	1e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—AKT1—epilepsy syndrome	4.66e-06	1e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—FYN—epilepsy syndrome	4.64e-06	1e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—RELA—epilepsy syndrome	4.64e-06	9.99e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—H2AFX—epilepsy syndrome	4.63e-06	9.96e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MEF2C—epilepsy syndrome	4.62e-06	9.95e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—SRC—epilepsy syndrome	4.61e-06	9.93e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—APOE—epilepsy syndrome	4.58e-06	9.87e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MTOR—epilepsy syndrome	4.55e-06	9.8e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—SRC—epilepsy syndrome	4.54e-06	9.78e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—FYN—epilepsy syndrome	4.54e-06	9.78e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—MTOR—epilepsy syndrome	4.53e-06	9.75e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—H2AFX—epilepsy syndrome	4.53e-06	9.75e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL1B—epilepsy syndrome	4.52e-06	9.73e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MEF2C—epilepsy syndrome	4.52e-06	9.73e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—VEGFA—epilepsy syndrome	4.49e-06	9.67e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—KDR—epilepsy syndrome	4.49e-06	9.67e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—PTGS2—epilepsy syndrome	4.49e-06	9.66e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—YWHAZ—epilepsy syndrome	4.46e-06	9.61e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—AKT1—epilepsy syndrome	4.43e-06	9.55e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—VEGFA—epilepsy syndrome	4.43e-06	9.53e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NGF—epilepsy syndrome	4.41e-06	9.5e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—JUN—epilepsy syndrome	4.38e-06	9.43e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—YWHAZ—epilepsy syndrome	4.37e-06	9.4e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—AKT1—epilepsy syndrome	4.37e-06	9.4e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—AKT1—epilepsy syndrome	4.33e-06	9.32e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PRKCB—epilepsy syndrome	4.32e-06	9.31e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NGF—epilepsy syndrome	4.32e-06	9.3e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL6ST—epilepsy syndrome	4.31e-06	9.27e-06	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—AKT1—epilepsy syndrome	4.3e-06	9.26e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCR5—epilepsy syndrome	4.29e-06	9.25e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CASP3—epilepsy syndrome	4.29e-06	9.24e-06	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—AKT1—epilepsy syndrome	4.23e-06	9.1e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HTR2A—epilepsy syndrome	4.2e-06	9.05e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCR5—epilepsy syndrome	4.2e-06	9.04e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—AKT1—epilepsy syndrome	4.19e-06	9.03e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CASP3—epilepsy syndrome	4.19e-06	9.01e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—JUN—epilepsy syndrome	4.17e-06	8.97e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HTR2A—epilepsy syndrome	4.11e-06	8.85e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—AKT1—epilepsy syndrome	4.09e-06	8.81e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—JUN—epilepsy syndrome	4.07e-06	8.76e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MMP9—epilepsy syndrome	4.05e-06	8.73e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—AKT1—epilepsy syndrome	4.03e-06	8.68e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TSC2—epilepsy syndrome	3.99e-06	8.6e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—AGT—epilepsy syndrome	3.99e-06	8.58e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	3.97e-06	8.54e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MMP9—epilepsy syndrome	3.96e-06	8.52e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—POMC—epilepsy syndrome	3.94e-06	8.48e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—AKT1—epilepsy syndrome	3.93e-06	8.46e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—SRC—epilepsy syndrome	3.93e-06	8.46e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CAT—epilepsy syndrome	3.91e-06	8.43e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—APOE—epilepsy syndrome	3.91e-06	8.41e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TSC2—epilepsy syndrome	3.91e-06	8.41e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—AGT—epilepsy syndrome	3.9e-06	8.4e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCL2—epilepsy syndrome	3.85e-06	8.3e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—AKT1—epilepsy syndrome	3.84e-06	8.26e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—KDR—epilepsy syndrome	3.83e-06	8.24e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—APOE—epilepsy syndrome	3.82e-06	8.23e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	3.81e-06	8.2e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—KDR—epilepsy syndrome	3.74e-06	8.06e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—SRC—epilepsy syndrome	3.74e-06	8.05e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PRKCB—epilepsy syndrome	3.68e-06	7.93e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL6ST—epilepsy syndrome	3.67e-06	7.9e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—SRC—epilepsy syndrome	3.65e-06	7.85e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—VEGFA—epilepsy syndrome	3.64e-06	7.84e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—SRC—epilepsy syndrome	3.63e-06	7.81e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PRKCB—epilepsy syndrome	3.6e-06	7.76e-06	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—AKT1—epilepsy syndrome	3.6e-06	7.74e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—AKT1—epilepsy syndrome	3.59e-06	7.73e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL6ST—epilepsy syndrome	3.59e-06	7.73e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—VEGFA—epilepsy syndrome	3.55e-06	7.65e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GPX1—epilepsy syndrome	3.54e-06	7.62e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—FGF2—epilepsy syndrome	3.48e-06	7.5e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—AKT1—epilepsy syndrome	3.43e-06	7.38e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—POMC—epilepsy syndrome	3.36e-06	7.23e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—AKT1—epilepsy syndrome	3.32e-06	7.14e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCL2—epilepsy syndrome	3.28e-06	7.07e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—POMC—epilepsy syndrome	3.28e-06	7.07e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—RELA—epilepsy syndrome	3.23e-06	6.96e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCL2—epilepsy syndrome	3.21e-06	6.92e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MTOR—epilepsy syndrome	3.17e-06	6.83e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—AGT—epilepsy syndrome	3.1e-06	6.68e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—APOE—epilepsy syndrome	3.04e-06	6.55e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	2.97e-06	6.39e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CASP3—epilepsy syndrome	2.92e-06	6.28e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	2.9e-06	6.25e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—AKT1—epilepsy syndrome	2.87e-06	6.17e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—JUN—epilepsy syndrome	2.83e-06	6.1e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—AKT1—epilepsy syndrome	2.82e-06	6.08e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—AKT1—epilepsy syndrome	2.78e-06	5.98e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MMP9—epilepsy syndrome	2.76e-06	5.93e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	2.75e-06	5.93e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	2.7e-06	5.82e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	2.69e-06	5.8e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—AKT1—epilepsy syndrome	2.67e-06	5.75e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	2.64e-06	5.69e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—POMC—epilepsy syndrome	2.61e-06	5.62e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—SRC—epilepsy syndrome	2.54e-06	5.47e-06	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.51e-06	5.4e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	2.48e-06	5.35e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—VEGFA—epilepsy syndrome	2.47e-06	5.33e-06	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	2.45e-06	5.28e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—AKT1—epilepsy syndrome	2.44e-06	5.26e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	2.43e-06	5.23e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	2.41e-06	5.2e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ALB—epilepsy syndrome	2.38e-06	5.13e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	2.36e-06	5.08e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	2.35e-06	5.06e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—AKT1—epilepsy syndrome	2.32e-06	5e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	2.3e-06	4.95e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	2.28e-06	4.9e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—AKT1—epilepsy syndrome	2.27e-06	4.88e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—AKT1—epilepsy syndrome	2.25e-06	4.85e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	2.23e-06	4.8e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	2.17e-06	4.66e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	2.12e-06	4.56e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	2.11e-06	4.54e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	2.08e-06	4.49e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	2.06e-06	4.44e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—AKT1—epilepsy syndrome	1.58e-06	3.4e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	1.35e-06	2.9e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	1.32e-06	2.83e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—AKT1—epilepsy syndrome	1.05e-06	2.25e-06	CbGpPWpGaD
